FDA Orange Book · active-ingredient family
Trypan blue
Trypan blue is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:MEMBRANEBLUE · NDA 022278
2
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| MEMBRANEBLUERLD | DORC | NDA 022278 | — | Feb 20, 2009 | |
| VISIONBLUERLD | DORC | NDA 021670 | — | Dec 16, 2004 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Trypan blue — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

